| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $1.3M | — |
| SG&A Expense | $3.8M | — |
| Operating Income | -$5.1M | — |
| Income Tax | $0 | — |
| Net Income | -$4.9M | — |
| EPS (Basic) | -$0.18 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Current Assets | $3.3M | +2.5% |
| Total Assets | $12.5M | +75.0% |
| Current Liabilities | $1.9M | +538.3% |
| Total Liabilities | $2.7M | +134.0% |
| Stockholders' Equity | $9.8M | +63.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | — |
| Capital Expenditures | $4.5M | — |
| Investing Cash Flow | -$4.5M | — |
| Financing Cash Flow | $6.6M | — |
| Free Cash Flow | -$7.4M | — |